Depressive Symptoms May Be Associated With Survival in Patients With Hematologic Malignancies
Patients with lymphoma or myeloma were assessed prior to and 1 month after initiating chemotherapy for depressive symptoms.
Depressive Disorder
Identifying Factors Related to Inpatient Psychiatric Readmissions for Youth
Youth who are readmitted for inpatient psychiatric care share such factors as foster care, comorbid conditions, and prior psychiatric hospitalizations.
CPAP Alleviates Depression in Obstructive Sleep Apnea
The benefit of CPAP was seen for depression but not anxiety symptoms in patients with obstructive sleep apnea.
Predictors of Depression Trajectory in Older Patients Identified
Chronic disease burden and baseline symptom severity were identified as consistent risk factors for negative depression trajectories in older adults.
Genetic Risk for Major Depression Increases Suicidality Across Psychiatric Disorders
Genetic liability for major depression increases the risk for suicide attempts in major depressive disorder, bipolar disorder, and schizophrenia.
Antidepressants May Lower Mortality Risk in Patients With Diabetes, Depression
Screening for and treating depression in patients with diabetes may be associated with a lower mortality risk.
Ketamine for Depression: Clinical Evidence and Concerns
Ketamine is gaining ground as a promising option for treatment-resistant depression, but not every clinician is buying in. We review clinical evidence and concerns surrounding the drug.
Benzodiazepine Monotherapy Often Used for Depression Contrary to Guidelines
Benzodiazepine monotherapy continues to be used to treat depression despite American Psychiatric Association guidelines, and even in cases of concomitant opioid use.
The Asthma-Mental Health Connection: Expert Clinicians Weigh In
Patients with asthma have demonstrated an elevated risk for depression and anxiety that is potentially twice as high as that in the general population.
Short-Term Benzodiazepines May Improve Information Processing in Acute MDD
Treatment with benzodiazepines for less than 3 months may not decrease the cognitive function of patients with major depressive disorder who are also prescribed antidepressants.
Next post in Depressive Disorder
